Catching HBV early can make a world of difference. Medical professionals typically use blood tests that check for signs of ...

Aligos Therapeutics is a clinical-stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases. The company is dedicated to educating ...

In April 2025, Vir Biotechnology Inc. announced a phase 1b/2 platform study framework to evaluate the safety and efficacy of ...

Interim results from the phase 2b B-Clear showed that bepirovirsen ... below the lower limit of detection in people with chronic hepatitis B, raising hopes that it could offer permanent cure ...

GSK’s antisense-based drug for chronic hepatitis B (CHB), bepirovirsen ... granted to bepirovirsen largely on the back of the phase 2b B-Clear trial reported in 2022, which found that ...

In adults with chronic hepatitis B infection receiving viral suppression ... B surface antigen (HBsAg), according to a ...

Gyre Therapeutics (GYRE) announced the publication of the manuscript titled “Hydronidone for the Treatment of Liver Fibrosis Associated with ...